Melotto; Sergio Patent Filings

Patent	Date
Use Of Azabicyclo Hexane Derivatives App 20120196910 - HAMPRECHT; Dieter ; et al.	2012-08-02
1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders App 20100286151 - Bentley; Jonathan ; et al.	2010-11-11
I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating Disorders App 20100197699 - Bentley; Jonathan ; et al.	2010-08-05
Chemical Compounds App 20090042897 - Bentley; Jonathan ; et al.	2009-02-12
Use of Azabicyclo Hexane Derivatives App 20090036461 - Hamprecht; Dieter ; et al.	2009-02-05
Combinations of paroxetine and 2-(r)-(4-fluoro-2-methyl-phenyl)-4-(s)-((8as)-6-oxo-hexahydro-pyrrolo'1,2- -a!-pyrazin-2-yl)-piperidine-1-carboxylicacid'1-(r)-(3,5-bis-trifluorometh- yl-phenyl)- App 20060287325 - Melotto; Sergio	2006-12-21
Combinations comprising paroxetine and 2- (s) - (4-fluoro-2-methyl-phenyl) -piperazine-1-carboxylic acid [1- (r)- (3,5-bis-trifluoro-2-methyl-phenyl) -ethyl]-methyl amide for treatment of depression and/or anxiety App 20060241124 - Carletti; Renzo ; et al.	2006-10-26
Combination of paroxetine and 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2s-phenyl-piperidin- -3s-yl)-amine for treatment of depression and/or anxiety App 20060241143 - Melotto; Sergio	2006-10-26
Combinations of paroxetine and 4- (s) - (4-acetyl-piperazin-1-yl) -2- (r)- (4-fluoro-2-methyl- phenyl -piperidine-1-carboxylic acid [1- (r) (3,5-bis-trifluoromethyl-phenyl) -ethyl] methylamide for treatment of depression and / or anxiety App 20060217395 - Carletti; Renzo ; et al.	2006-09-28
Chemical compounds Grant 6,951,861 - Alvaro , et al. October 4, 2	2005-10-04

Patent

Date

Use Of Azabicyclo Hexane Derivatives
App 20120196910 - HAMPRECHT; Dieter ; et al.

2012-08-02

1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders
App 20100286151 - Bentley; Jonathan ; et al.

2010-11-11

I-OXA-3-Azaspiro (4.5) Decan-2-One And 1-OXA-3, 8-Diazaspiro (4.5) Decan-2-One Derivatives For The Treatment of Eating Disorders
App 20100197699 - Bentley; Jonathan ; et al.

2010-08-05

Chemical Compounds
App 20090042897 - Bentley; Jonathan ; et al.

2009-02-12

Use of Azabicyclo Hexane Derivatives
App 20090036461 - Hamprecht; Dieter ; et al.

2009-02-05

Combinations of paroxetine and 2-(r)-(4-fluoro-2-methyl-phenyl)-4-(s)-((8as)-6-oxo-hexahydro-pyrrolo'1,2- -a!-pyrazin-2-yl)-piperidine-1-carboxylicacid'1-(r)-(3,5-bis-trifluorometh- yl-phenyl)-
App 20060287325 - Melotto; Sergio

2006-12-21

Combinations comprising paroxetine and 2- (s) - (4-fluoro-2-methyl-phenyl) -piperazine-1-carboxylic acid [1- (r)- (3,5-bis-trifluoro-2-methyl-phenyl) -ethyl]-methyl amide for treatment of depression and/or anxiety
App 20060241124 - Carletti; Renzo ; et al.

2006-10-26

Combination of paroxetine and 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2s-phenyl-piperidin- -3s-yl)-amine for treatment of depression and/or anxiety
App 20060241143 - Melotto; Sergio

2006-10-26

Combinations of paroxetine and 4- (s) - (4-acetyl-piperazin-1-yl) -2- (r)- (4-fluoro-2-methyl- phenyl -piperidine-1-carboxylic acid [1- (r) (3,5-bis-trifluoromethyl-phenyl) -ethyl] methylamide for treatment of depression and / or anxiety
App 20060217395 - Carletti; Renzo ; et al.

2006-09-28

Chemical compounds
Grant 6,951,861 - Alvaro , et al. October 4, 2

2005-10-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Melotto; Sergio

Patent Applications and Registrations